30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?

Jacobus Adrianus Burgers, Ronald Alphons Damhuis

Source: ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018
Journal Issue: October
Disease area: Thoracic oncology

Congress or journal article abstractFull text journal articlePDF journal article, handout or slides

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Jacobus Adrianus Burgers, Ronald Alphons Damhuis. 30-day mortality after the start of systemic anticancer therapy for lung cancer: is it really a useful performance indicator?. ERJ Open Res, 4 (4) 00030-2018; 10.1183/23120541.00030-2018

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.

Related content which might interest you:
Preoperative physiological data and lung cancer surgery: do the same factors predict post-operative morbidity/mortality and long term survival?
Source: Annual Congress 2005 - Prognostic factors in lung cancer
Year: 2005

Impact of COPD on prognosis of lung cancer: the prespective of immunotherapy treatment
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021

Evaluation of cardiovascular risk in a lung cancer screening cohort: what value does it bring?
Source: Breathe, 16 (4) 200204; 10.1183/20734735.0204-2020
Year: 2020

Introducing a new prognostic instrument for long-term mortality prediction among COPD patients - the CADOT index.
Source: International Congress 2019 – Advances in clinical management of COPD
Year: 2019

Prediction of long-term effect of anti-angiogenic therapy in lung cancer patients by monitoring early changes in circulating-tumor DNA (ctDNA).
Source: Virtual Congress 2020 – Biological aspects of lung cancer
Year: 2020

First hospitalization in lung cancer patients – is timing important?
Source: Virtual Congress 2021 – Screening, diagnosis, management and prognosis of lung cancer
Year: 2021

Long-term survival in lung cancer after surgery: is gender a prognostic factor?
Source: Eur Respir J 2001; 18: Suppl. 33, 229s
Year: 2001

Impact of interstitial lung disease and simultaneous lung cancer on therapeutic possibilities and survival
Source: International Congress 2019 – Comorbidities of idiopathic pulmonary fibrosis
Year: 2019

What outcome after the prescription of neoadjuvant chemotherapy in lung cancer?
Source: Annual Congress 2011 - Instructive clinical aspects of lung cancer
Year: 2011

Effect of statin therapy in patients with lung cancer on mortality, incidence of infections and pulmonary embolism
Source: Annual Congress 2012 - Screening, diagnosis, staging and treatment strategies for lung cancer
Year: 2012

Statins as adjunct therapy in COPD: is it time to target innate immunity and cardiovascular risk?
Source: Eur Respir J, 58 (1) 2100342; 10.1183/13993003.00342-2021
Year: 2021

Are biphosphonates efficient in the adjuvant treatment of lung cancer?
Source: Eur Respir J 2006; 28: Suppl. 50, 754s
Year: 2006

Evaluation of causes and characteristics of lung cancer mortality
Source: Eur Respir J 2005; 26: Suppl. 49, 321s
Year: 2005

Comparison of predictive respiratory function parameters of lung cancer patients having COPD diagnosis with postoperative values and relation with mortality and morbidity
Source: Annual Congress 2011 - Imaging, functional evaluation and staging for lung cancer patients
Year: 2011

Does the incorporation of new generation cytotoxic agent improve the overall outcome in inoperable nonsmall cell lung cancer (NSCLC)?
Source: Eur Respir J 2003; 22: Suppl. 45, 64s
Year: 2003

Optimising treatment for post-operative lung cancer recurrence
Source: Eur Respir J 2016; 47: 374-378
Year: 2016

Lung clearance index for evaluation of late complications of cancer therapy in children
Source: International Congress 2019 – A mixture of rare lung diseases
Year: 2019

Metformin improves survival in lung cancer patients receiving EGFR-TKIs therapy>
Source: International Congress 2018 – Lung cancer: from the bench to the bedside
Year: 2018

The effect of nutritional indicators on prognosis of patients with advanced lung cancer
Source: International Congress 2019 – Symptoms, risks, complications and palliative care in thoracic oncology
Year: 2019